Author

Kathryn Lyle

Institution: University of Alabama at Birmingham Hospital

Observed institutions: University of Alabama at Birmingham Hospital, University of Alabama at Birmingham

OpenAlex ID: A5113424758

A phase II study evaluating carboplatin/paclitaxel/pembrolizumab among newly diagnosed stage III/IV epithelial ovarian cancer patients receiving neoadjuvant chemotherapy followed by olaparib/pembrolizumab maintenance

2024 · Kaitlyn Kincaid, Peter Ketch, et al. · Gynecologic Oncology · 1

A phase II study in newly diagnosed stage III/IV epithelial ovarian cancer evaluating carboplatin/paclitaxel/pembrolizumab in patients receiving neoadjuvant chemotherapy (NACT) followed by pembrolizumab maintenance with or without olaparib

2026 · Carson Edwards, Kati Turner, et al. · Gynecologic Oncology

A phase Ib/II single-arm study of cabozantinib plus dostarlimab among women with recurrent gynecologic carcinosarcoma

2024 · Peter Ketch, Alexandra North, et al. · Gynecologic Oncology

Works count: 3

Citation count: 1

H-index: 1

I10-index: